Support your weight loss goals with Semaglutide, a once-weekly injection designed to reduce appetite, control cravings, and promote sustainable weight management.
Semaglutide injections are a non-surgical medical weight loss treatment that regulates appetite and metabolism to help individuals lose weight. This treatment mimics a naturally occurring hormone that helps control hunger and digestion. Semaglutide shots are administered once weekly and function by slowing gastric emptying, increasing feelings of fullness, and reducing overall food intake. This leads to long-term weight loss that is gradual and sustainable. Weight loss injections with semaglutide support long-term weight management by helping individuals maintain a calorie deficit while improving metabolic function. This treatment is designed to reduce overall body fat rather than target specific areas.
Semaglutide is a non-surgical, once-weekly injectable treatment for medical weight management. It mimics a naturally occurring hormone that helps regulate appetite, hunger, and digestion. Semaglutide works by slowing gastric emptying, increasing feelings of fullness, and reducing overall food intake, making it easier to maintain a calorie deficit and achieve gradual, sustainable weight loss. It is designed to reduce overall body fat rather than target fat in specific areas. According to Dermalign Medical Aesthetics, Semaglutide can also support improved insulin sensitivity, blood sugar control, portion control, and long-term weight management when combined with healthy lifestyle habits.
Because Semaglutide supports whole-body weight reduction, patients may experience fat loss across areas such as:
Semaglutide slows gastric emptying, increases feelings of fullness, and reduces overall food intake, making it easier to maintain a calorie deficit and achieve gradual, sustainable weight loss.
Results vary based on metabolism, diet, physical activity, and other individual factors. According to Dermalign, many patients may experience a 10%–15% reduction in body weight over several months with consistent use and healthy lifestyle habits.
Semaglutide may be recommended for adults with a BMI of 27 or higher with weight-related health conditions, or adults with a BMI of 30 or higher seeking medical support for weight loss.
The page states that Semaglutide may not be appropriate for individuals with certain conditions, including thyroid cancer, pancreatitis, severe gastrointestinal illness, or specific endocrine disorders, or for those who are pregnant or breastfeeding.
Semaglutide injections are administered once weekly, usually in the abdomen, thigh, or upper arm. Dosages may be adjusted according to your progress and response to treatment.
